BIB vs IBBQ

ProShares Ultra NASDAQ Biotechnology against Invesco Nasdaq Biotechnology ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
58%
245 shared positions
Fee gap
76 bp
IBBQ is cheaper
1-year return gap
32.2 pts
BIB is ahead
Larger fund
BIB
$96M

Side by side

BIBIBBQ
FundProShares Ultra NASDAQ BiotechnologyInvesco Nasdaq Biotechnology ETF
IssuerProSharesInvesco
CategoryLeveraged EquityBiotech & Health Innovation
Expense ratio0.95%0.19%
Assets$96M$67M
Average daily dollar volume$842K$1.5M
ListedApr 6, 2010Jun 11, 2021
FrenzyCap score4463
1-month return−2.1%−0.4%
3-month return+15.8%+8.6%
Year to date+43.8%+24.1%
1-year return+66.7%+34.5%
30-day volatility50.7%25.5%
Worst drawdown, 1 year−17.9%−9.2%
Trailing 12-month yield0.20%1.11%
Holdings256261
Top 10 weight157.8%40.7%
Look-through P/E——
Holdings vs fair value+3.4%+6.8%
Holdings above 200-day average78%67%
Net flow, latest 3 reported months−$14M thru May 2026−$7.6M thru May 2026
30-day implied volatility49.1%27.5%
Holdings as ofas of Oct 21, 2026issuer dataas of May 31, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

61% of BIB · 98% of IBBQ
HoldingBIBIBBQ
GILD5.12%7.39%
AMGN4.97%7.11%
VRTX4.70%7.38%
REGN3.25%5.08%
ILMN1.70%1.98%
RVMD1.66%2.48%
MRNA3.92%1.48%
BIIB1.42%2.29%
ALNY1.20%3.19%
RPRX1.10%1.90%
ROIV1.06%1.71%
ARGX0.97%1.89%
UTHR0.96%1.94%
INCY0.92%1.53%
GH0.89%1.35%
VTRS0.85%1.49%
INSM0.82%1.83%
MEDP0.74%1.01%
EXEL0.64%1.04%
ASND0.59%1.10%
NBIX0.57%1.26%
HALO0.56%0.63%
ONC0.55%0.73%
JAZZ0.55%1.16%
BBIO0.54%1.02%

Sector mix of the stock holdings

SectorBIBIBBQGap
Health Care58.3%96.8%−38.5%
Technology2.6%3.1%−0.5%
Materials0.0%0.0%−0.0%

More: full overlap table · BIB holdings · IBBQ holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.